Medley Genomics

Medley Genomics is the first company dedicated to addressing the challenges of genomic heterogeneity in the diagnosis and treatment of complex diseases. Initially focused on oncology, their goal is not only to characterize the primary tumor mutation profiles obtained from mixed tumor cell populations but also to expand this data to define unique mutation profiles seen in heterogeneous tumor cell subpopulations to better inform treatment decisions. Medley was founded to leverage advanced analytical methods to assess complex genomic heterogeneity in biological samples and support targeted therapies.